Search results
Caplin Point is a fast growing, fully integrated Pharmaceutical company with a dominant presence in Latin America, Francophone Africa and a growing presence in the Regulated markets such as USA and EU. The company was established in 1990 to manufacture a range of ointments, creams and other external applications.
Caplin Point is a fast growing, fully integrated Pharmaceutical company with a dominant presence in Latin America, Francophone Africa and a growing presence in the Regulated markets such as USA and EU.
Caplin Point was established in 1990 to manufacture a range of ointments, creams and other external applications. The Company was listed in 1994 following its Initial Public Offering (IPO) which was oversubscribed 117 times, the proceeds of which were deployed in setting up a manufacturing facility at Pondicherry.
Caplin Point Laboratories Ltd. 3rd Floor, Ashvich Towers, No 3, Developed Plots Industrial Estate, Perungudi, Chennai 600096. Tamil Nadu, India.
The Caplin Point management is headed by Chairman Shri.C.C.Paarthipan, supported by a professional management team under the guidance of. Mr. C.C.Paarthipan. EXECUTIVE SUMMARY. A first generation entrepreneur, C.C.Paarthipan’s stint in the Pharmaceutical industry goes back almost 3 decades.
Caplin Point was established in 1990 to manufacture a range of ointments, creams and other external applications. The Company was listed in 1994 following its Initial Public Offering (IPO) which was oversubscribed 117 times, the proceeds of which were deployed in setting up a manufacturing facility at Pondicherry.
Aug 16, 2024 · Caplin Point Laboratories Limited is possibly the only mid-sized company in India’s pharmaceutical sector to be engaged in the R&D and manufacture of finished formulations, APIs, clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility.
Caplin Point was established in 1990 to manufacture a range of ointments, creams and other external applications. The Company was listed in 1994 following its Initial Public Offering (IPO) which was oversubscribed 117 times, the proceeds of which were deployed in setting up a manufacturing facility at Pondicherry.
Caplin Point Laboratories Ltd Unit-I (CP-I) is a Colombia-INVIMA and WHO-GMP approved facility, catered towards emerging markets of Latin America and Africa: The facility has state of the art equipment manufacturing the following dosage forms: Sterile Liquid & Lyophilized Injectables; Pre-Filled Syringes (Single & Dual-Chamber) Tablets; Capsules
When you join Caplin Point, you’re not only joining one of the best performing mid-cap Pharma companies in India, you’re part of a company that believes it can challenge status quo in the industry and time and again proves that obstacles can always be converted into opportunities.
